Company intelligence / Profile preview

StimCardio Medical

Haifa, Israel

Ownership: Private
Development stage: Other

Overview

StimCardio Medical is an Israeli medical device company focused on developing innovative neuromodulation and cardiac stimulation therapies for heart failure. The company's primary technology is a minimally invasive, catheter-based system designed to enhance cardiac contractility and improve hemodynamic function in patients with heart failure. By utilizing targeted electrical stimulation, StimCardio aims to provide a safer and more effective alternative to traditional cardiac resynchronization therapies. The company is currently advancing its lead device through early-stage development and feasibility testing within the Trendlines incubator.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on StimCardio Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on StimCardio Medical.

Explore the full profile